In support, Sharifnia et al. [33] deployed an ORF-based kinase screen to identify potential bypass signaling pathways in EGFR mutant PC9 lung cancer cells and identified both FGFR2 and FGFR1 (see below). The gene discussed is FGFR1; the disease is lung carcinoma.